CHMP

News

J&J’s COVID-19 shot backed for emergency use in EU

The EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot from Johnson & Johnson’s Janssen unit – after a review by it

News

scientifically visualization of a coronavirus spike protein

EMA backs emergency use of Lilly’s COVID antibodies

The EMA’s human medicines committee has said two Eli Lilly antibodies are effective in people with COVID-19 who are at risk of developing severe disease, clearing the way for use in EU memb

News

CHMP clears way for EU approval of Novartis' MS drug

Novartis’ multiple sclerosis drug has been given the green light by the European Medicines Agency’s CHMP scientific committee, paving the way for a likely approval in the coming weeks.

News

The unprecedented challenge of pricing a coronavirus vaccine

EMA approves AZ’s COVID-19 vaccine – including for over-65s

The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18, despite assertions in Germany this week that it shouldn’t be used in elderly people.

News

Daiichi Sankyo, AZ close on EU approval of Enhertu for breas...

Daiichi Sankyo and AstraZeneca could be just weeks away from an EU approval for their antib

News

Roche’s Herceptin/Perjeta combo product nears EU approval

The EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin and Perjeta – part of the company’s defense against Hercept

J&J’s COVID-19 shot backed for emergency use in EU

EMA backs emergency use of Lilly’s COVID antibodies

CHMP clears way for EU approval of Novartis' MS drug

EMA approves AZ’s COVID-19 vaccine – including for over-65s

Daiichi Sankyo, AZ close on EU approval of Enhertu for breas...

Roche’s Herceptin/Perjeta combo product nears EU approval

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

CHMP

Editor's Picks